Here we demonstrate that targeting ERAP1 and treatment with the HDACi entinostat curbed NB growth in vivo, making tumors more infiltrated by CD8+ T-cells and responsive to PD-1 blockade. The gene discussed is CD8A; the disease is neuroblastoma.